- This topic is empty.
Viewing 0 reply threads
-
Posts
-
-
The U.S. Food and Drug Administration approved a shorter infusion time of Ocrevus (ocrelizumab) for people with relapsing or primary progressive MS. Read the full story here.
What are your thoughts on this news?
-
Viewing 0 reply threads
- You must be logged in to reply to this topic.
